1. Lynda Molnar Lynda Molnar United States says:

    people wonder why it takes so long to get a drug from discovery to patients. Blanchette Rockefeller Neurological Institute (BRNI) was granted permission by the FDA to begin clinical trial for Bryostatin, June 2009. Here it is more than five years later and they are just beginning a clinical trial. They posted a professional grade video on-line singing the praises of Bryostatin and BRNI being sure to show the name tags of the researchers involved. They received a patent covering the use of Bryostatin to treat alzheimer's disease.  Makes you wonder how badly they really want to find a treatment for AD. Sad to see human beings behave in such a manner.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.